In addition, the expression of ASCL1 or NEUROD1 on immunohistochemistry, as biomarkers associated with BrMs, was associated with worse CNS outcomes in BrM-free SCLC patients at diagnosis [177]. The gene discussed is ASCL1; the disease is small cell lung carcinoma.